Nasdaq panel grants SeaStar Medical continued listing exception until June 22, 2025

SeaStar Medical Holding Corp

Nasdaq Hearings Panel granted continued listing subject to compliance with Nasdaq Listing Rule 5550(b)(2) (MVLS Rule) requiring $35M market value by June 22, 2025.
Company must file public disclosure describing equity-increasing transactions and provide updated fundraising plans and income projections by June 22, 2025.
SeaStar is continuing fundraising efforts begun in 2024 and states confidence in meeting all requirements within the specified timeframes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.